Results: 444

Adaptação cardiovascular no Teste de Caminhada dos Seis Minutos em pacientes com DPOC: estudo transversal

Rev. Pesqui. Fisioter; 9 (1), 2019
OBJETIVO: Avaliar o comportamento da adaptação cardiovascular e da saturação periférica de oxigênio em indivíduos com DPOC submetidos no teste de caminhada dos seis minutos (TC6). MATERIAL E MÉTODOS: Trata-se de um estudo de corte transversal, que foram incluídas pessoas com diagnóstico de DPOC...

Supervivencia en una cohorte de pacientes con enfermedad pulmonar obstructiva crónica acorde a la clasificación GOLD 2017
Survival in a cohort of patients with chronic obstructive pulmonary disease according to GOLD 2017 classification

Medicina (B.Aires); 79 (1), 2019
Hasta el momento, no existe información sobre la evolución de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) de acuerdo con la nueva clasificación GOLD 2017. El objetivo de este estudio fue determinar, en una cohorte de pacientes con EPOC seguidos por veinte años, la influencia del...

Estrategias de problematización e intervención de Kinesiología / Fisioterapia para un paciente con una afección ventilatoria crónica reagudizada

La Clasificación Internacional del Funcionamiento, de la Discapacidad y de la Salud (CIF), permite organizar la información mediante un lenguaje trans-disciplinario. Al respecto, es fundamental complementarlo con una epistemología propia para generar prácticas clínicas eficientes. La enfermedad pulm...

La enfermedad pulmonar obstructiva crónica infradiagnosticada y su severidad en adultos de 40 a 70 años con infecciones respiratorias a repetición ligados o no al tabaquismo en el Hospital Nacional General de Neumología y Medicina Familiar "Dr. José Antonio Saldaña" en el periodo de junio a diciembre de 2017

La enfermedad pulmonar obstructiva crónica (EPOC) está infra diagnosticada y causa morbilidad y mortalidad alrededor del mundo. Adultos de edad media y adultos mayores con cualquier tipo de enfermedad respiratoria y con historia de tabaquismo tienen una alta probabilidad de tener EPOC infra diagnostica...

Update on the approach to smoking in patients with respiratory diseases

J. bras. pneumol; 45 (3), 2019
ABSTRACT Smoking is the leading cause of respiratory disease (RD). The harmful effects of smoking on the respiratory system begin in utero and influence immune responses throughout childhood and adult life. In comparison with "healthy" smokers, smokers with RD have peculiarities that can impede smoking c...

Multidisciplinary education with a focus on COPD in primary health care

J. bras. pneumol; 45 (6), 2019
ABSTRACT Objective: To evaluate the use of video lessons on the topic of COPD as a training tool for a multidisciplinary team working in the primary health care sector. Methods: This was a quasi-experimental study involving a multidisciplinary team working at a primary health care clinic. The level of ...

Anthropometric status of individuals with COPD in the city of São Paulo, Brazil, over time - analysis of a population-based study

J. bras. pneumol; 45 (6), 2019
ABSTRACT Objective: To evaluate the anthropometric data obtained for residents of the city of São Paulo, Brazil, in a study of Latin America conducted in two phases (baseline, in 2003, and follow-up, in 2012). Methods: This was an analysis of data obtained for São Paulo residents in a two-phase popul...

Estudo pré-clínico do potencial terapêutico do análogo de mexiletina, JME-209: impacto na inflamação pulmonar induzida por fumaça de cigarro

A doença pulmonar obstrutiva crônica (DPOC) é uma disfunção inflamatória que acomete os pulmões, caracterizada pela obstrução progressiva e parcialmente irreversível das vias aéreas. Atualmente, inexistem medicamentos que possam controlar satisfatoriamente os quadros inflamatório e enfisemato...

Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting

Clinics; 74 (), 2019
OBJECTIVE: Muscle wasting contributes to the reduced quality of life and increased mortality in chronic obstructive pulmonary disease (COPD). Muscle atrophy in mice with cachexia was caused by Activin A binding to ActRIIB. The role of circulating Activin A leading to muscle atrophy in COPD remains elusiv...